Compare American Electric Power Company Inc (AEP) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Electric Power Company Inc vs Davita Inc — how do they compare? American Electric Power Company Inc trades at $123.63 (market cap $67.28B), while Davita Inc trades at $179.02 (market cap $11.38B). The key difference: American Electric Power Company Inc is far larger — about 5.9× Davita Inc's market cap, and American Electric Power Company Inc pays a 3.07% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| AEP | DVA | |
|---|---|---|
Market Cap | $67.28B | $11.38B |
Sector | Utilities | Health |
52-Week High | $138.69 | $240.96 |
52-Week Low | $106.44 | $103.87 |
Enterprise Value | $120.17B | $24.10B |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Electric Power Company Inc
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
